Document is current
Any future updates will be listed below
-
Authors
Huang, Chengchi https://orcid.org/0000-0002-4543-6751
Tian, Hong https://orcid.org/0000-0003-1715-6362
-
Funding
Funding for this research was provided by:
National Eye Institute (R01EY036417)
National Eye Institute (R01EY027749)
National Eye Institute (R24EY028764)
National Eye Institute (R21EY035421)
National Eye Institute (R44EY027665)
National Eye Institute (R43EY032827)
- License Information
-
More Information
Article History
Received: 11 March 2025
Accepted: 3 June 2025
First Online: 15 June 2025
Declarations
:
: HT and WL are shareholders of Everglades Biopharma, LLC and LigandomicsRx, LLC. WL is an inventor of issued and pending patents. CH declares no competing financial interests.
